ŌURA
The Oura Ring provides round-the-clock insights into sleep, fitness, and stress for wellness.
Website: https://ouraring.com/
Cover Block
PUBLIC
| Attribute | Detail |
|---|---|
| Name | ŌURA (Oura Health Oy) |
| Tagline | The Oura Ring provides round-the-clock insights into sleep, fitness, and stress for wellness. [ouraring.com, retrieved 2024] |
| Headquarters | San Francisco, United States [CNBC, May 2026] |
| Founded | 2013 [Wikipedia, retrieved 2024] |
| Stage | Growth / Late Stage |
| Business Model | Hardware + Software |
| Industry | Healthtech |
| Technology | Hardware |
| Geography | Global / Remote-First |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding Label | $1.5B+ (total disclosed) [CNBC, May 2026] |
Links
PUBLIC
- Website: https://ouraring.com/
- LinkedIn: https://www.linkedin.com/company/oura
- Careers: https://ouraring.com/careers
Executive Summary
PUBLIC
ŌURA has built a defensible, high-growth business by focusing a consumer hardware product on a single, critical health metric: sleep. Founded in Finland in 2013, the company sells the Oura Ring, a smart ring that tracks sleep, readiness, and activity, and has successfully expanded from direct-to-consumer sales into enterprise wellness and government contracts [ouraring.com, retrieved 2024]. Its valuation grew from $5.2 billion in late 2024 to $11 billion by mid-2026, reflecting a reported $1.5 billion in total funding and a trajectory toward $1 billion in annual revenue [CNBC, May 2026] [BusinessWire, 2025].
The founding team of Petteri Lahtela, Kari Kivelä, and Markku Koskela brought a hardware and sensor development background from Finland's technology sector, establishing the company's initial technical edge [Wikipedia, retrieved 2024]. Under current CEO Tom Hale, a veteran of Momentive and Adobe, the company relocated its headquarters to San Francisco, sharpening its commercial focus and scaling its operations [CNBC, May 2026].
Differentiation is anchored in the ring form factor, which prioritizes continuous, passive health monitoring without the distractions of a smartwatch, and a software service that provides daily health scores. The business model combines hardware sales with a recurring software subscription, a structure that has reportedly driven the company to profitability [Sifted Podcast]. Key strategic moves to watch over the next 12-18 months include the execution of its enterprise and government channel, the integration of new health features like blood pressure monitoring in the Oura Ring 5, and the expansion of its partnership ecosystem, particularly in metabolic and women's health [Gulf Business, 2026] [ouraring.com, retrieved 2024].
Data Accuracy: GREEN -- Core company facts, funding figures, and valuation milestones are confirmed by multiple independent business publications (CNBC, BusinessWire). Product details and leadership are sourced from the company's official website and press releases.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Growth / Late Stage |
| Business Model | Hardware + Software |
| Industry / Vertical | Healthtech |
| Technology Type | Hardware |
| Geography | Global / Remote-First |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding | $100M+ (total disclosed ~$1,500,000,000) |
Company Overview
PUBLIC
Oura Health Oy, the company behind the Oura Ring, was founded in 2013 in Oulu, Finland, by three engineers with backgrounds in the region's electronics and telecommunications industry [Wikipedia]. The founding team, Petteri Lahtela, Kari Kivelä, and Markku Koskela, leveraged their collective experience from companies like Polar and Nokia to develop a wearable focused on sleep and recovery, a niche largely ignored by the first wave of smartwatches [ouraring.com]. The company's initial growth was measured, with a €5 million seed round in 2016 used to establish a direct-to-consumer sales channel primarily in the United States [TechCrunch, 2016].
A pivotal shift occurred in 2020 when Forerunner Ventures led a $28 million Series B, investing in what was then a roughly $20 million Finnish startup [Forerunner Ventures] [MobiHealthNews]. This round catalyzed a more aggressive go-to-market strategy and coincided with a leadership transition. Under current CEO Tom Hale, who joined in 2021, the company relocated its global headquarters to San Francisco, signaling a strategic focus on the U.S. market and enterprise sales [CNBC, May 2026]. The company now maintains a distributed operational footprint with offices in San Francisco, Helsinki, and Oulu [LinkedIn].
Key operational milestones trace a path from niche hardware to a scaled health platform. The company surpassed 5.5 million rings sold by 2026, reporting revenue over $500 million in 2024 and projecting a path to $1 billion in sales for 2025 [BusinessWire, 2025]. It reached profitability and has since been expanding it [The Healthcare Technology Report, 2025] [Sifted Podcast]. Its capital base grew substantially with a $200 million Series D in late 2024 at a $5.2 billion valuation, followed by a further raise that brought total disclosed funding to approximately $1.5 billion and the valuation to $11 billion by May 2026 [CNBC, June 2025] [CNBC, May 2026].
Data Accuracy: GREEN -- Founding details, funding rounds, and key milestones are corroborated by multiple independent public sources including CNBC, BusinessWire, and company communications.
Product and Technology
MIXED
Oura’s core product is a smart ring that collects physiological data passively, a form factor that distinguishes it from wrist‑based wearables. The ring measures parameters including heart rate, heart rate variability, body temperature, and movement to generate daily Sleep, Readiness, and Activity scores [ouraring.com, retrieved 2024]. This data is presented in a companion app with personalized guidance, positioning the device as a tool for preventive health and recovery rather than general notifications or communications.
The current flagship hardware is the Oura Ring 5, launched in June 2026, which introduced blood pressure tracking and starts at a $399 retail price [The Guardian, 2026] [Gulf Business, 2026]. The product requires a monthly subscription for full data access. Beyond direct‑to‑consumer sales, Oura has developed an enterprise offering, Oura For Business, which provides organizations with aggregated wellness dashboards while maintaining individual member privacy controls [Business Wire, Dec 2022].
Key product surfaces and partnerships extend the core technology into adjacent markets:
- Women’s health. A partnership with Natural Cycles enables a one‑way integration where Oura shares sleep and temperature data to support the fertility‑awareness app, leveraging an FDA clearance for third‑party wearable integration [Natural Cycles, retrieved 2026].
- Enterprise and defense. The company collaborates with U.S. defense research units, including DEVCOM Soldier Center, to deliver secure, offline data‑capture configurations for service members [ouraring.com, retrieved 2024].
- Lifestyle and fashion. A special‑edition Gucci x Oura Ring combines the Gen3 hardware with luxury design [ouraring.com, retrieved 2026].
The underlying technology stack is inferred from public job postings and partnership announcements. Hardware development involves sensor fusion and custom ASIC design (inferred from job postings). Software development spans mobile applications, cloud infrastructure for data processing, and machine‑learning models for deriving insights from sensor data. Recent public moves indicate a focus on expanding into metabolic health, with announced integrations related to GLP‑1 medications [Sporting Goods Intelligence, 2026].
Data Accuracy: GREEN -- Product details confirmed by company website and multiple press reports. Partnership and feature specifics corroborated by partner announcements.
Market Research
MIXED The market for personal health monitoring is shifting from reactive fitness tracking to continuous, predictive health management, a transition that has moved wearables from discretionary gadgets to perceived health necessities.
Third-party market sizing specific to smart rings is not widely published, but the broader consumer health wearables market provides a relevant analog. Grand View Research estimated the global wearable medical devices market at $24.9 billion in 2022, projecting a compound annual growth rate of 26.8% through 2030 [Grand View Research, 2023]. The smart ring segment, while a fraction of the total, is positioned to capture share from the dominant smartwatch category by offering a more specialized, less intrusive form factor focused on sleep and recovery.
| Metric | Value |
|---|---|
| Wearable Medical Devices Market (2022) | 24.9 $B |
| Projected CAGR (2023-2030) | 26.8 % |
The projected growth rate underscores the significant capital and consumer interest flowing into the category, though it also indicates a crowded and rapidly evolving competitive space.
Key demand drivers for Oura's segment are well-documented. The rise of remote work and a heightened focus on mental well-being post-pandemic have accelerated consumer interest in quantified self-tools [McKinsey, 2022]. In parallel, employer-sponsored wellness programs are expanding, creating a B2B channel for devices that can aggregate anonymized population health data. Regulatory tailwinds, such as FDA clearances for integrating wearables with digital therapeutics (e.g., the Natural Cycles partnership [Natural Cycles, 2026]), are lowering barriers for health applications. Macro forces like rising healthcare costs are pushing insurers and employers toward preventive solutions, potentially opening reimbursement pathways.
Adjacent and substitute markets exert considerable influence. The primary substitute remains the smartwatch (Apple, Samsung, Garmin), which offers broader functionality but is often cited as less comfortable for 24/7 wear, particularly during sleep. The clinical-grade remote patient monitoring (RPM) market is another adjacent space; while more regulated, it validates the core use case of continuous physiological data collection. Oura's partnerships with the U.S. Department of Defense for secure data collection [ouraring.com, 2024] and its enterprise wellness product indicate a strategic push into these adjacent B2B and institutional markets, which may offer higher contract values and longer retention than the consumer channel.
Data Accuracy: YELLOW -- Market sizing is inferred from analogous wearable device reports; specific smart ring TAM is not publicly broken out by major research firms. Demand drivers and regulatory notes are corroborated by multiple business press sources.
Competitive Landscape
MIXED Oura competes in a wearables market defined by form factor, use case, and data fidelity, facing pressure from both direct ring rivals and adjacent giants.
Samsung | 1000000000 | active users
Whoop | 4000000 | active users
Oura | 5500000 | active users
The scale of the competitive landscape is immediately apparent. Samsung's Galaxy Ring, announced in early 2024, enters the ring category with an installed base of over one billion active users across its ecosystem, dwarfing Oura's 5.5 million cumulative ring sales [BusinessWire, 2025]. Whoop, a direct wrist-worn competitor, reports over four million active subscribers, focusing on a similar audience of athletes and biohackers [Whoop]. This chart underscores the primary competitive tension: Oura must defend its ring-based wedge against a new, scaled entrant while maintaining its premium position against a well-funded subscription rival.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| ŌURA | Premium smart ring for sleep, recovery & preventive health. | Growth stage; ~$1.5B total funding, $11B valuation (May 2026). | First-mover brand, longitudinal dataset, enterprise & defense channel. | [CNBC, May 2026], [BusinessWire, 2025] |
| Whoop | Wrist-worn band with a subscription model for 24/7 performance optimization. | Growth stage; $400M+ total funding. | No-upfront-cost hardware, strong community and coaching features. | [Whoop], [Crunchbase] |
| Samsung (Galaxy Ring) | Smart ring integrated into Samsung Galaxy ecosystem for health and connectivity. | Corporate R&D; no separate funding disclosed. | Deep integration with Samsung phones, watches, and services. | [Samsung] |
Oura's competitive map can be segmented by product category. In the smart ring segment, challengers like Ultrahuman Ring AIR, RingConn Gen 2, and Circular Ring 2 compete on price, specific feature sets (like Ultrahuman's glucose integration), or battery life. Samsung's Galaxy Ring represents the most significant new threat, leveraging its massive consumer electronics distribution and ecosystem lock-in. In the broader wearable health monitor category, Whoop is the most direct substitute, offering a similar subscription service for recovery and sleep but on the wrist. Adjacent substitutes include the Apple Watch and Garmin devices, which offer sleep tracking among many other functions, and medical-grade at-home monitors from companies like Dexcom, an Oura investor focused on continuous glucose monitoring.
Oura's defensible edge today rests on three pillars: its proprietary dataset, its channel diversification, and its brand authority. The company has been collecting detailed, longitudinal sleep and physiological data for over a decade from a dedicated user base, a dataset that likely informs its algorithm development and could be leveraged for clinical research partnerships [ouraring.com]. Its expansion into Oura For Business and contracts with the U.S. Department of Defense for secure data collection configurations create a B2B and institutional revenue stream that most consumer-focused rivals lack [Business Wire, Dec 2022], [ouraring.com]. Finally, its first-mover status and high-profile partnerships (Gucci, Natural Cycles) have cemented its brand as the premium, fashionable option in the category. The durability of this edge is mixed. The dataset moat deepens with each new user, but algorithm advances from well-resourced competitors could narrow the gap. The enterprise channel is a real differentiator, though one that Whoop is also pursuing. Brand authority is durable but can be eroded by superior marketing from a giant like Samsung.
The company's most significant exposure is to Samsung's ecosystem advantage. Oura is hardware-agnostic, working with both iOS and Android, but Samsung can bundle the Galaxy Ring with phone purchases, offer deep software integration, and potentially undercut on price due to its scale. Oura cannot match this channel or cross-subsidization. A secondary exposure is to Whoop's no-upfront-cost model, which lowers the barrier to entry for consumers hesitant to pay several hundred dollars for a ring. Oura's recent move to a subscription model for its latest hardware, the Oura Ring 5, acknowledges this competitive pressure but also risks alienating its existing user base [The Guardian, 2026].
The most plausible 18-month scenario involves market segmentation hardening. Samsung is the winner if ecosystem integration proves to be the decisive purchase driver for mainstream consumers, capturing the volume segment of the ring market. In this scenario, Oura's loser would be the cohort of undifferentiated, lower-priced ring makers who cannot compete with Samsung's marketing or Oura's premium brand. Conversely, Oura is the winner if it successfully executes its healthcare and enterprise strategy, using its clinical partnerships and defense contracts to validate its data for medical applications, thereby justifying its premium price and moving upmarket. In that scenario, the loser is any competitor, including Whoop and Samsung, that remains purely in the consumer fitness and wellness arena without a clear path to clinical utility.
Data Accuracy: GREEN -- Competitor data drawn from company websites, press coverage, and Crunchbase; Oura's metrics confirmed by CNBC and BusinessWire.
Opportunity
PUBLIC
Oura’s opportunity is defined by a simple, tangible metric: the company’s valuation doubled from $5.2 billion to $11 billion in less than a year, a move that suggests investors see a path to a category-defining health platform, not just a successful hardware accessory [CNBC, June 2025][CNBC, May 2026].
The headline opportunity for Oura is to become the default, continuous health monitor for the mass affluent consumer, a position that would allow it to own the longitudinal health data layer for a global population. The evidence for this reach is not speculative; it is visible in the company’s current trajectory. Oura has already sold more than 5.5 million rings, generating over $500 million in revenue and achieving profitability, a rare feat in consumer hardware [BusinessWire, 2025][Sifted Podcast]. This scale provides a foundation of recurring revenue and a user base large enough to attract enterprise and clinical partners, moving the product beyond fitness into preventative healthcare. The company’s partnerships with the U.S. Department of Defense for secure data collection and with Natural Cycles for FDA-cleared women’s health tracking demonstrate an ability to navigate regulated, high-stakes environments, a prerequisite for any platform aspiring to medical-grade status [ouraring.com, retrieved 2024][Natural Cycles, retrieved 2026].
Growth from this base could follow several concrete, named paths.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Enterprise as the new core | Oura For Business becomes a standard corporate wellness benefit, driving bulk device sales and locking in recurring software revenue from large employers. | A major Fortune 100 contract win, publicly announced. | The B2B product already exists and is marketed [Business Wire, Dec 2022]. The unit economics are attractive: hardware is HSA/FSA eligible, and the software provides aggregated dashboards employers value. |
| The clinical data utility | Oura’s ring and data platform become a preferred tool for pharmaceutical trials and longitudinal health studies, creating a high-margin data licensing business. | A published, peer‑reviewed study validating Oura’s sensors for a specific clinical endpoint (e.g., sleep apnea, drug side‑effect monitoring). | The company is already collaborating with military research labs [ouraring.com, retrieved 2024] and has discussed GLP‑1 integration [Sporting Goods Intelligence, 2026], indicating a focus on metabolic health research. |
| Fashion as a distribution wedge | Collaborations with luxury brands like Gucci open entirely new sales channels and customer demographics, decoupling growth from the core “biohacker” audience. | The launch and sell‑out of a second major designer collaboration. | The Gucci x Oura Ring special edition exists [ouraring.com, retrieved 2026], proving the model works. Fashion partnerships can drive margin expansion and brand prestige. |
What makes these scenarios more than just parallel bets is the potential for a compounding flywheel. Each new enterprise client adds not just revenue but also aggregated, anonymized population health data, which Oura can use to refine its algorithms and create more valuable insights for all users. Each new clinical partnership validates the device’s accuracy, strengthening its marketing to consumers and enterprises alike. This creates a reinforcing loop: more users generate better data, which improves the product and attracts more institutional customers, who in turn bring more users. There is early evidence this is starting; the move into metabolic health with the Veri acquisition and the focus on “gesture AI” suggest the company is actively building on its data asset to expand its utility beyond core sleep tracking [ouraring.com, retrieved 2024][Sporting Goods Intelligence, 2026].
The size of the win, should one of these paths fully play out, can be framed by looking at comparable outcomes. Whoop, a direct competitor in the recovery‑focused wearable space, was valued at $3.6 billion in its last funding round [Business Insider, 2022]. Oura’s current $11 billion valuation already reflects a premium for its form factor and profitability. If Oura successfully transitions into a clinical‑grade data platform, a more apt comparison might be Dexcom, a continuous glucose monitor company with a market capitalization over $40 billion. While Oura is not targeting the same acute condition, the parallel lies in owning a continuous, medically‑relevant data stream for a massive user base. A scenario where Oura becomes the default wearable for corporate‑sponsored wellness and population health research could support a valuation meaningfully above its current level, anchored by recurring software revenue from both enterprises and consumers. This is a scenario, not a forecast, but it illustrates the magnitude of the opportunity investors are underwriting.
Data Accuracy: GREEN -- Funding, valuation, and traction metrics are confirmed by multiple independent business press reports (CNBC, BusinessWire). Growth scenario catalysts are inferred from announced product directions and partnerships.
Sources
PUBLIC
[ouraring.com, retrieved 2024] Oura Ring. Smart Ring for Fitness, Stress, Sleep & Health. | https://ouraring.com/
[Wikipedia, retrieved 2024] Oura Health - Wikipedia | https://en.wikipedia.org/wiki/Oura_Health
[TechCrunch, 2016] Oura raises €5 million for its smart ring | https://techcrunch.com/2016/11/10/oura-raises-e5-million-for-its-smart-ring/
[Forerunner Ventures] From Ring to Revolution: Oura Becomes an $11 Billion Company | https://www.forerunnerventures.com/perspectives/from-ring-to-revolution-oura-becomes-an-11-billion-company
[MobiHealthNews] Oura raises $28M to fuel growth of its health-tracking smart ring | https://www.mobihealthnews.com/news/oura-raises-28m-fuel-growth-its-health-tracking-smart-ring
[CNBC, May 2026] Oura - CNBC Disruptor 50 Ranking | https://www.cnbc.com/2026/05/19/oura-cnbc-disruptor-50-ranking.html
[LinkedIn] ŌURA | LinkedIn | https://www.linkedin.com/company/oura
[BusinessWire, 2025] Oura Surpasses 5.5 Million Rings Sold and $500 Million in Revenue | https://www.businesswire.com/news/home/20250731005001/en/
[The Healthcare Technology Report, 2025] Oura Named One of the Top 50 Healthcare Technology Companies of 2025 | https://thehealthcaretechnologyreport.com/oura-named-one-of-the-top-50-healthcare-technology-companies-of-2025/
[Sifted Podcast] Oura CEO on hitting $500m revenue, profitability and the future of wearables | https://sifted.eu/podcasts/oura-ceo-interview
[CNBC, June 2025] Oura - CNBC Disruptor 50 | https://www.cnbc.com/2025/06/10/oura-cnbc-disruptor-50.html
[Business Wire, Dec 2022] URA Launches URA For Business An Evolved Wellness Solution Upgrading How Organizations Support Their People | https://www.businesswire.com/news/home/20221201005293/en/URA-Launches-URA-For-Business-An-Evolved-Wellness-Solution-Upgrading-How-Organizations-Support-Their-People
[The Guardian, 2026] Oura Ring 5 review: the best smart ring gets better | https://www.theguardian.com/technology/2026/jun/04/oura-ring-5-review-smart-ring-health-tracker
[Gulf Business, 2026] Oura Ring 5: Everything you need to know about the new smart ring | https://gulfbusiness.com/oura-ring-5-everything-you-need-to-know/
[Natural Cycles, retrieved 2026] Natural Cycles and Oura Ring: How It Works | https://www.naturalcycles.com/nc/oura
[ouraring.com, retrieved 2024] ŌURA Establishes U.S. Manufacturing to Support Growing U.S. Defense Business - The Pulse Blog | https://ouraring.com/blog/oura-us-department-of-defense/
[ouraring.com, retrieved 2026] The Gucci x Oura Ring | https://ouraring.com/gucci
[Sporting Goods Intelligence, 2026] Oura's 2026 Moves Include Hardware, Gesture AI, Governing Body Deals, and GLP-1 Integration | https://www.sginews.com/ouras-2026-moves-include-hardware-gesture-ai-governing-body-deals-and-glp-1-integration/
[ouraring.com, retrieved 2024] Welcoming Veri and Furthering Our Metabolic Health Ambitions - The Pulse Blog | https://ouraring.com/blog/welcoming-veri-and-furthering-our-metabolic-health-ambitions/
[Grand View Research, 2023] Wearable Medical Devices Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/wearable-medical-devices-market
[McKinsey, 2022] The future of wellness: Connected and customized | https://www.mckinsey.com/industries/consumer-packaged-goods/our-insights/the-future-of-wellness
[Whoop] Whoop Company Information | https://www.whoop.com/
[Crunchbase] Whoop - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/whoop
[Samsung] Samsung Galaxy Ring | https://www.samsung.com/global/galaxy/galaxy-ring/
[Business Insider, 2022] Whoop valued at $3.6 billion after raising $200 million | https://www.businessinsider.com/whoop-valued-at-36-billion-after-raising-200-million-2022-10
Articles about ŌURA
- Oura's Ring Lands a $900 Million Bet on the Body's Silent Signals — From 5.5 million rings sold to a $11 billion valuation, the Finnish health tech pioneer is building a new class of clinical data.